NCT06237504

The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Yonsei University · Academic / Other
• Sex: All
• Age: 95 Years
• Healthy volunteers: Not accepted

Summary

This study aims to investigate whether the use of a video LMA device (SacoVLM™) will facilitate successful supraglottic airway device (SAD) insertion compared to the use of a conventional 2nd generation SAD (Ambu®Auragain™) in elderly patients. This study is a randomized trail with a 50% probability of being assigned to either group. Randomization will be done by an anesthesiologist not involved in anesthesia or postoperative outcome assessment. Patients and the investigator in charge of postoperative outcomes assessment will be blinded to group allocation.

Conditions

• Elderly
• Laryngeal Mask Airway
• General Anesthesia

Interventions

Type	Name	Description
DEVICE	SaCoVLM™	Patients will receive general anesthesia with their airways maintained with the SaCoVLM, which is a newer supraglottic airway device with a video port to directly visualize the upper airway.
DEVICE	Ambu®Auragain™	Patients will receive general anesthesia with their airways maintained with the Ambu Auragain, which is a conventional 2nd generation supraglottic airway device.

Timeline

• Start date: 2024-02-01
• Primary completion: 2026-01-01
• Completion: 2026-01-01
• First posted: 2024-02-01
• Last updated: 2024-02-01

Locations

1 site across 1 country: South Korea